COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
About this item
Full title
Author / Creator
Publisher
United States: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
United States: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate...
Alternative Titles
Full title
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5e8e4a3a9ff6450689be81e3c46f7d8a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5e8e4a3a9ff6450689be81e3c46f7d8a
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2610.201816
